New therapeutic strategies in the management of systemic sclerosis
- 22 March 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 8 (5) , 607-615
Abstract
(2007). New therapeutic strategies in the management of systemic sclerosis. Expert Opinion on Pharmacotherapy: Vol. 8, No. 5, pp. 607-615. doi: 10.1517/14656566.8.5.607Keywords
This publication has 56 references indexed in Scilit:
- Stimulatory Autoantibodies to the PDGF Receptor in Systemic SclerosisNew England Journal of Medicine, 2006
- T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase IJournal of Autoimmunity, 2006
- DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti–topoisomerase I autoantibodies from systemic sclerosis patientsArthritis & Rheumatism, 2006
- Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patientsRheumatology, 2006
- Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array ApproachPLOS Medicine, 2005
- Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarraysCurrent Opinion in Rheumatology, 2005
- Autoantibodies to Fibrillin-1 Activate Normal Human Fibroblasts in Culture through the TGF-β Pathway to Recapitulate the “Scleroderma Phenotype”The Journal of Immunology, 2005
- Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cellsArthritis & Rheumatism, 2004
- Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohortsArthritis & Rheumatism, 2001
- Severe organ involvement in systemic sclerosis with diffuse sclerodermaArthritis & Rheumatism, 2000